ASX - By Stock
|
ALA |
Re:
Ann: Proposed issue of securities - ALA
|
|
abitlikeme
|
3 |
1.5K |
9 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
3
|
1.5K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
abitlikeme
|
692 |
275K |
4 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
692
|
275K
|
4
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Proposed issue of securities - ALA
|
|
abitlikeme
|
3 |
1.5K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
3
|
1.5K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
abitlikeme
|
692 |
275K |
5 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
692
|
275K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
abitlikeme
|
422 |
146K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
422
|
146K
|
0
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ALA-101 and onCARlytics collaboration update
|
|
abitlikeme
|
62 |
27K |
8 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
62
|
27K
|
8
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ALA-101 and onCARlytics collaboration update
|
|
abitlikeme
|
62 |
27K |
4 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
62
|
27K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
abitlikeme
|
692 |
275K |
9 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
692
|
275K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
abitlikeme
|
144 |
64K |
11 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
64K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
abitlikeme
|
422 |
146K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
422
|
146K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
abitlikeme
|
422 |
146K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
422
|
146K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
abitlikeme
|
422 |
146K |
7 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
422
|
146K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
abitlikeme
|
422 |
146K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
422
|
146K
|
2
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Notification regarding unquoted securities - ALA
|
|
abitlikeme
|
1 |
518 |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
1
|
518
|
2
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ALA-101 and onCARlytics collaboration update
|
|
abitlikeme
|
62 |
27K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
62
|
27K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
abitlikeme
|
422 |
146K |
6 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
422
|
146K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
abitlikeme
|
422 |
146K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
422
|
146K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
abitlikeme
|
692 |
275K |
9 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
692
|
275K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Ann: US patent allowed for CHM 0201 (CORE-NK) technology
|
|
abitlikeme
|
15 |
5.2K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
15
|
5.2K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: US patent allowed for CHM 0201 (CORE-NK) technology
|
|
abitlikeme
|
15 |
5.2K |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
15
|
5.2K
|
4
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Arovella Completes $12.5M Placement - Funded to Phase 1 Data
|
|
abitlikeme
|
34 |
14K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
34
|
14K
|
1
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Arovella Completes $12.5M Placement - Funded to Phase 1 Data
|
|
abitlikeme
|
34 |
14K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
34
|
14K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
abitlikeme
|
216 |
96K |
6 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
216
|
96K
|
6
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Arovella Completes $12.5M Placement - Funded to Phase 1 Data
|
|
abitlikeme
|
34 |
14K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
34
|
14K
|
2
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Arovella Completes $12.5M Placement - Funded to Phase 1 Data
|
|
abitlikeme
|
34 |
14K |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
34
|
14K
|
1
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Arovella Completes $12.5M Placement - Funded to Phase 1 Data
|
|
abitlikeme
|
34 |
14K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
34
|
14K
|
3
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Appendix 4E differences to full year statutory accounts
|
|
abitlikeme
|
11 |
3.7K |
4 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
11
|
3.7K
|
4
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ALA-101 and onCARlytics collaboration update
|
|
abitlikeme
|
62 |
27K |
6 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
62
|
27K
|
6
|
|
ASX - By Stock
|
ENX |
Re:
Ann: Tenement Granted at Rocky Ridge Gold Prospect
|
|
abitlikeme
|
7 |
2.4K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
7
|
2.4K
|
1
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ALA-101 and onCARlytics collaboration update
|
|
abitlikeme
|
62 |
27K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
62
|
27K
|
1
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Arovella to present at AACR annual meeting
|
|
abitlikeme
|
3 |
1.1K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
3
|
1.1K
|
5
|
|
ASX - By Stock
|
ENX |
Re:
Ann: Tenement Granted at Rocky Ridge Gold Prospect
|
|
abitlikeme
|
7 |
2.4K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
7
|
2.4K
|
1
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Arovella Completes $12.5M Placement - Funded to Phase 1 Data
|
|
abitlikeme
|
34 |
14K |
7 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
34
|
14K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Clinical milestones for 2024 & 2023 successes highlighted
|
|
abitlikeme
|
26 |
9.2K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
26
|
9.2K
|
2
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Arovella Completes $12.5M Placement - Funded to Phase 1 Data
|
|
abitlikeme
|
34 |
14K |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
34
|
14K
|
6
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Trading Halt
|
|
abitlikeme
|
32 |
13K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
32
|
13K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Clinical milestones for 2024 & 2023 successes highlighted
|
|
abitlikeme
|
26 |
9.2K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
26
|
9.2K
|
1
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Trading Halt
|
|
abitlikeme
|
32 |
13K |
4 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
32
|
13K
|
4
|
|
ASX - By Stock
|
ENX |
Re:
Ann: Tenement Granted at Rocky Ridge Gold Prospect
|
|
abitlikeme
|
7 |
2.4K |
3 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
7
|
2.4K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric to present at NWR Virtual Healthcare Conference
|
|
abitlikeme
|
22 |
7.2K |
5 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
22
|
7.2K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric to present at NWR Virtual Healthcare Conference
|
|
abitlikeme
|
22 |
7.2K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
22
|
7.2K
|
4
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ALA-101 and onCARlytics collaboration update
|
|
abitlikeme
|
62 |
27K |
10 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
62
|
27K
|
10
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ALA-101 and onCARlytics collaboration update
|
|
abitlikeme
|
62 |
27K |
4 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
62
|
27K
|
4
|
|
ASX - By Stock
|
ALA |
Re:
Ann: ALA-101 and onCARlytics collaboration update
|
|
abitlikeme
|
62 |
27K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
62
|
27K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
abitlikeme
|
422 |
146K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
422
|
146K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
abitlikeme
|
422 |
146K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
422
|
146K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
abitlikeme
|
422 |
146K |
3 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
422
|
146K
|
3
|
|
ASX - By Stock
|
ALA |
Re:
Breakout Looming?
|
|
abitlikeme
|
351 |
154K |
5 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
351
|
154K
|
5
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading March 11
|
|
abitlikeme
|
134 |
28K |
1 |
11/03/24 |
11/03/24 |
ASX - Day Trading
|
134
|
28K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
abitlikeme
|
692 |
275K |
6 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
692
|
275K
|
6
|
|